Registered entities
Geneos Therapeutics, Inc.
Reg. No. 81-3107759United States
Innovation
4 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 114 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Social engagement
Social engagement: 2.7K social following, 6 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Sante, Flerie, Global Bio Fund, 3B Future Health Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 1 | 14% |
| Bank & private debt | 1 | 14% |
| Other / undisclosed | 1 | 14% |
Recent activity
21 May 2026
Event
American Society of Clinical Oncology (ASCO) annual conference
30 Jan 2026
Event
10th Annual Liquid Biopsy for Precision Oncology Summit
6 Jan 2026
Event
Advancing Personalized Cancer Immunotherapies